Copyright
©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 102201
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.102201
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.102201
Table 3 The cumulative recurrence rates and overall survival rates of 181 advanced gastric cancer patients undergoing gastrectomy and prophylactic hyperthermic intraperitoneal chemotherapy
Rates | 1 year | 2 years | 3 years | Median OS |
Overall survival rates | 96.1% | 75.1% | 53.6% | 41.3 months |
- Citation: Wang L, Chen MZ, Liu L, Jiang ZN, Zhang SM, Zhang MS, Zhang XX, Liu RQ, Wang DS. Novel inflammatory-nutritional prognostic index for advanced gastric cancer patients undergoing gastrectomy and prophylactic hyperthermic intraperitoneal chemotherapy. World J Gastrointest Surg 2025; 17(5): 102201
- URL: https://www.wjgnet.com/1948-9366/full/v17/i5/102201.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i5.102201